Find a Job



KEYWORDS:

LOCATION:

CATEGORY:

Advanced Search

Or find a job by:

Region/Town | Commute | Employer | Industry

 

 NEWSLETTERS
Sign up for one of the newsletter e-mails listed
here for the latest job news, tips, and more!

Employer Profile
Nucryst Pharmaceuticals
Quick Facts
Stock Symbol:
WEDX
Corporate HQ:
Wakefield, MA
Employer Home Page:
www.nucryst.com/
Employer Careers Page:
www.nucryst.com/index.asp?p=2&s=15

View all Nucryst Pharmaceuticals jobs on BostonWorks.com


Company Description:

Do research on this employer:

NUCRYST Pharmaceuticals researches and develops medical devices and pharmaceutical applications based on the science of noble metal nanotechnology.

NUCRYST's pharmaceutical research and development operations offer a challenging and leading-edge professional and scientific environment for individuals who want to play a role in the creation of new pharmaceutical and medical device products.

There are a range of opportunities throughout the organization in both the Wakefield, Massachusetts and Fort Saskatchewan, Alberta locations.

NUCRYST offers a competitive compensation and benefits package and the opportunity to work with an exciting technology in a growing organization.

NUCRYST's 19,000-square-foot worldwide company headquarters and pharmaceutical research and development operations are based in Wakefield, Massachusetts

Quick Facts:

  • All product manufacturing takes place in Fort Saskatchewan, Alberta, Canada
  • NUCRYST's management team has a combined total of more than 100 years of pharmaceutical and biotechnology management expertise
  • NUCRYST™ employs highly-specialized scientists and engineers in the development of its noble metal nanocrystalline pharmaceutical and medical device technologies
  • The company's first product, Acticoat™ Burn Dressing, is used today in more than 100 of the 120 major burn hospitals in North America
  • NUCRYST™ has partnered with Smith & Nephew, the world leader in advanced wound care, for the global sales, marketing and distribution of Acticoat™ burn and chronic wound dressings
  • NUCRYST™ Pharmaceuticals holds 14 U.S. issued patents and is currently pursuing ten additional U.S. patent applications related to its noble metal anti-microbial technology